1 / 39

RLS & Associates, Inc.

Understanding the Updated USDOT Drug & Alcohol Testing Regulation (49 CFR Part 40). Presented by: Robbie L. Sarles President RLS & Associates, Inc. April 4, 2018. RLS & Associates, Inc. REMEMBER!. RLS is NOT is not an official or representative of:

braunm
Download Presentation

RLS & Associates, Inc.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Understanding the Updated USDOT Drug & Alcohol Testing Regulation (49 CFR Part 40) Presented by: Robbie L. Sarles President RLS & Associates, Inc. April 4, 2018 RLS & Associates, Inc.

  2. REMEMBER! • RLS is NOT is not an official or representative of: • United States Department of Transportation (USDOT) • USDOT – Office of Drug & Alcohol Policy and Compliance (ODAPC) • Any USDOT – Agency • (i.e., FTA, FMCSA, FRA, FAA, PHMSA, etc.)

  3. Best Practices • NOT Required by USDOT, FTA or Any Other Modal Administration • NOT A Regulatory Requirement • Addresses Issues That Might Already Be Covered Under Employer’s Own Company/Agency Authority ATTENTION: ANY TEXT WHICH IS BLUE IS MEANT TO INDICATE THAT IT IS NOT A USDOT REQUIREMENT/REGULATION. THESE PROVISIONS WOULD BE BEST-PRACTICES/SUGGESTIONS AND UNDER THE AUTHORITY OF THE EMPLOYER

  4. AGENDA

  5. Action Items • When you see a red star throughout this slideshow – this will indicate to you that there is a potential ACTION ITEM for your attention.

  6. Background 49 CFR Part 40 U S D O T FAA FMCSA USCG PHMSA FRA FTA RLS & Associates, Inc.

  7. Background • “The What?” • 49 CFR Part 40 is USDOT’sD&A regulation covering testing procedures • Part 40 has been updated • “The When?” • Jan 2017 – USDOT issued NPRM • Nov 2017 – Final Rule published in Federal Register • Jan 1, 2018 – Effective Date for all changes

  8. Background • “The Who?” • Applicable to entire DOT industry (FTA, FMCSA, FRA, FAA, PHMSA, USCG, etc.) • ANYONE subject to 49 CFR Part 40 • Employers, MROs, SAPs, Collection Sites, etc.

  9. Summary of Changes • Drug Testing Panel Modifications • “Opiate” changes to “Opioid” • Four new opioids added to testing panel

  10. Summary of Changes • Drug Testing Panel Modifications (continued) • “MDA” added to screening test • “MDEA” removed • Revisions / Updates to Terms & Definitions • “DOT, the Department, DOT agency” • Modified to encompass all DOT agencies, (FAA, FRA, FMCSA, FTA, PHMSA, NHTSA, OST, and any designee of a DOT agency) • Clarified USCG’s relationship with USDOT

  11. Summary of Changes • Revisions / Updates to Definitions (continued) • “Drugs” – modified to match the additions and revisions as discussed earlier • “Alcohol Screening Device” & “Evidential Breath Testing Device (EBT)” • List of approved devices now listed on ODAPC’s website (instead of in the federal register) • “Substance Abuse Professional” • List of qualified agencies for drug and alcohol counselor licenses/certificates will now be listed on ODAPC’s website

  12. Summary of Changes • ODAPC List-Serve • All service agents REQUIRED to “subscribe” • Sign-up via https://www.transportation.gov/odapc/get-odapc-email-updates • Prohibition of Use of Federal Branding, etc. • Blind Specimen Testing No Longer Required

  13. Summary of Changes • Urine Collection / Testing • Urine only allowable specimen (no blood, hair, sweat, etc.) • No DNA testing allowed • 3 new “Fatal Flaws” • No CCF with urine specimen at Lab • No urine specimen with CCF at Lab • Only if a specimen was actually collected • Two separate collections on only one CCF

  14. Summary of Changes • Urine Collection / Testing (continued) • Insufficient “Questionable Specimens” - Always discard & remark • New CCF Changes • Removed “DOT” box in Step 1D • Revised list of drugs in Step 5A

  15. Summary of Changes • Urine Collection / Testing (continued) • Use of “old” / “new” CCF • “New” CCF authorized for use Jan 1, 2018 • Continued use of old CCF authorized through June 30, 2018 • No ‘memorandum for the record required’ through June 30, 2018 for use of “old” CCF • “New” CCFMUST BE utilized July 1, 2018

  16. Summary of Changes • MRO Verification Process • Clarification of the term “prescription” • Prescription (Rx) must be consistent with Controlled Substances Act (CSA) • MRO-ordered additional testing • Authorized without prior ODAPC consent • Meth false positives due to Rx/OTC meds • Illicit THC vs. Marinol

  17. Summary of Changes • MRO Rx Verification Process • MRO release of information – Medically unqualified / Significant safety risk • Step 1 – Verify test result • Step 2 - Initial MRO determination • MRO notifies employee of medically unqualified / significant safety risk • Step 3 - Five-days for prescribing physician to contact MRO • Employee facilitates contact

  18. Summary of Changes • MRO Rx Verification Process (continued) • MRO release of information – Medically unqualified / Significant safety risk (continued) • Step 4 – Prescribing physician statement to MRO • Step 5 – Possible employer notification • Based on outcome of Steps 1 - 4

  19. Summary of Changes • Other Minor Misc. Changes • Removal of outdated compliance dates • Minor editorial corrections • Update/revisions to weblinks • Revisions to Appendix items

  20. Workplace Impact • Policy Revisions – • Change “opiate” to “opioid” • Remove (or edit) “breakdown” of 5-panel drug sub-categories • Remove (or edit) drug cut-off levels • Revise your “definitions” (if applicable) • ASD, EBT, SAP, DRUGS, USDOT

  21. Workplace Impact • Policy Revisions – BEST PRACTICES (NOT REQUIRED BY USDOT) • If your policy currently has a section on Rx/OTC medication use • Update to address MRO determinations of “Medically Unqualified / Significant Safety Risk” • If your policy DOES NOT have a Rx/OTC medication use section • Consider adding a short paragraph

  22. Workplace Impact • OTHER BEST PRACTICES (NOT REQUIRED BY USDOT) (continued) • Service Agent education • Summary of Regulatory changes • Make sure they have a copy of the revised regulation • Give them the link on how to sign-up for ODAPC’s List Serve • Require evidence that they actually signed up for ODAPC’s List-Serve

  23. Workplace Impact • “Medically Unqualified / Significant Safety Risk” • Final word is the MRO’s DISCRETION • What are the REAL implications? • Access to prescribing physician • Expiration of Rx • No recent contact to prescribing physician • What to do when/if you get the phone call • This is 100% employer’s determination (No USDOT regulation) • Unless USDOT- CDL medical standards apply

  24. Workplace Impact • “Medically Unqualified / Significant Safety Risk” • Employers should be pro-active in creating a “Fitness-for-duty/Wellness” policy (NOT A USDOT REGULATION) • Legal/Union/Collective Bargaining Concerns

  25. Implications • MRO Approach To Decision Making Process Is Not Defined In the Regulation • MRO discretion based on medical judgement • ODPAC Guidance Forthcoming • MRO philosophy, assessment of liability and risk management practices will influence approach • Case-by-case determination

  26. Implications • Possible MRO Determinations • Silent—No safety risk, no employer knowledge, no employer action • Notification of safety issue—Employer action • Follow procedure for CDL standard violation if appropriate • Liability Considerations • Human Resource • Legal Considerations • Collective Bargaining

  27. Best Practice • Proactively Discuss Philosophy and Procedures with MRO • If MRO Philosophy Is Inconsistent with Employer Philosophy or Intent of Regulation, Identify New MRO • If MRO Is Unwilling or Unable to Perform This Function, Identify New MRO • Define MRO Safety Issue Notification Procedures, Documentation and Timeline • Negotiate Cost of MRO Safety Assessment

  28. Implications • Employee Facilitation of Prescribing Physician/MRO Contact • Employees May Have Difficulty Accessing the Prescribing Physician In a Timely Manner • If More Than 5 Days Are Needed To Obtain an Appointment or Otherwise Get In Contact • The Prescribing Physician Is Unaware or Does Not Understand the Importance of the Contact • Employee Has Had No Recent Contact or Ongoing Relationship with the Prescribing Physician • Employee Does Not Know How to Facilitate the Contact Between the Physician and the MRO

  29. Best Practice • Assist Employees In Being Proactive • Educate Employees on Safety Risks of Rx • Provide A Summary of Regulatory Changes • ODAPC Notice • Review New/Revised Employer Policy • Define Process and Provide Guidance On How to Notify Prescribing Physician to Contact MRO

  30. Best Practice • Encourage Employees to Obtain Updated Rx • Current Rx Is More Than One Year Old • Rx States “Take As Needed” For An Injury That Is No Longer Being Treated By the Prescribing Physician • Employee Does Not Have an Ongoing Relationship with the Prescribing Physician • ER/Urgent Care or Doc-in-a-Box Physicians

  31. Best Practice • Encourage Employees to Obtain Updated Rx (cont.) • Revisit Treatment Options With Prescribing Physician for Chronic or Reoccurring Conditions To Minimize Safety Impacts While Not Compromising Medical Care • Encourage Employees Using Opioids to Discuss Dosing Option with Prescribing Physician • Timing • Dosage • Alternative Pain Management Options

  32. Best Practices • Provide Employees with a Physician Rx Medical Authorization Form • Job Description Highlighting Safety-Sensitive Duties • Area for Prescribing Physician to Indicate Possible Safety Risks With Corresponding Restrictions, If Any • Notification that Prescribing Physician May Be Contacted By MRO If A Safety Concern Exists

  33. Best Practices • Inform Applicants of Possible Prescribing Physician/MRO Contact Requirement • Provide Explicit Directions As Early on In the Hiring Process As Possible • Emphasize That a Valid Rx Does Not Necessarily Mean Disqualification. • Rx Is Only An Issue When It Rises to the Level of Safety Risk.

  34. Implications • Employer’s Response Not Defined • Assessment of Nature and Scope of Safety Risk • Short-term, Long-term, Permanent • Course of Action/Remedy • Monitoring Process and Revaluation • Medical Advisory and Decision Making Process • Employee Consequences And Due Process • Documentation, Record-keeping, and Confidentiality • Liability and Risk Management

  35. Employer Challenge • Best Practice Is to Develop An Effective Rx Fitness-for-Duty Program • A program that minimizes the associated impairment risks of taking legally and illegally obtained prescription medications while performing transit–related, safety-sensitive functions

  36. Best Practice • Establish a Fitness-for-Duty Program • Policy • Consequences • Medical Review of Employees Deemed to be a Safety Risk • Procedures • Employee Education • Documentation, Reporting, Confidentiality

  37. Questions?

  38. Resources • USDOT - ODAPC Resources • Final Rule: https://www.gpo.gov/fdsys/pkg/FR-2017-11-13/pdf/2017-24397.pdf • Brief summary of changes: https://www.transportation.gov/odapc/Part_40_Final_Rule_Summary_of_Changes • CCF Notice: https://www.transportation.gov/odapc/Notice_CCF_December_2017 • Policy Notice: https://www.transportation.gov/odapc/Part_40_DOT_Policies_Notice_2017 • Employee Notice: https://www.transportation.gov/odapc/Part_40_DOT_Employee_Notice_2017

  39. Resources • Other Resources • National RTAP Recorded Webinar (Part 40 Update): http://www.nationalrtap.org/Webinars#DrugAlcoholUpdate • National RTAP Recorded Webinar (Fitness For Duty): http://www.nationalrtap.org/Webinars#fitnessforduty • A more in-depth look at key factors in developing a fitness-for-duty policy

More Related